GW Pharma (GWPH) Shares Pressured; Abstract Confirms Interactions Between CBD and Clobazam in RE
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
GW Pharma (GWPH) Shares Reverse Earlier Drop, Move to Session Highs
November 21, 2016 2:38 PM ESTGW Pharma (NASDAQ: GWPH) shares have reversed earlier pressure and are now moving to session highs. The stock is up around 2.5 percent.
... MoreGW Pharma (GWPH) Active, Shares Decline
November 21, 2016 2:02 PM ESTGW Pharma (NASDAQ: GWPH) Active, Shares Decline
... More